Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Common Equity: 2018-2024

Historic Common Equity for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $744.4 million.

  • CureVac N.V's Common Equity rose 63.69% to $663.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $663.7 million, marking a year-over-year increase of 63.69%. This contributed to the annual value of $744.4 million for FY2024, which is 33.84% up from last year.
  • Latest data reveals that CureVac N.V reported Common Equity of $744.4 million as of FY2024, which was up 33.84% from $556.2 million recorded in FY2023.
  • In the past 5 years, CureVac N.V's Common Equity ranged from a high of $848.1 million in FY2020 and a low of $544.0 million during FY2022.
  • In the last 3 years, CureVac N.V's Common Equity had a median value of $556.2 million in 2023 and averaged $614.9 million.
  • Per our database at Business Quant, CureVac N.V's Common Equity spiked by 1,890.18% in 2020 and then crashed by 30.92% in 2022.
  • Yearly analysis of 5 years shows CureVac N.V's Common Equity stood at $848.1 million in 2020, then declined by 7.14% to $787.6 million in 2021, then slumped by 30.92% to $544.0 million in 2022, then climbed by 2.23% to $556.2 million in 2023, then soared by 33.84% to $744.4 million in 2024.